Nucleoside transporters in chronic lymphocytic leukaemia.
about
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapyRevisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 ÅCharacterization of the transport mechanism and permeant binding profile of the uridine permease Fui1p of Saccharomyces cerevisiae.Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignanciesBile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cellsUridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment.Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis.Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.Physiological and pharmacological roles of nucleoside transporter proteins.Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.6-Mercaptopurine transport in human lymphocytes: correlation with drug-induced cytotoxicityCurrent status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Mechanism of action of pentostatin and cladribine in hairy cell leukemia.Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells.Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase.Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells.Extracellular adenosine activates AMP-dependent protein kinase (AMPK).Glycodendrimer Nanocarriers for Direct Delivery of Fludarabine Triphosphate to Leukemic Cells: Improved Pharmacokinetics and Pharmacodynamics of Fludarabine.Transport of nucleosides in the vcCNT facilitated by sodium gradients from molecular dynamics simulations.OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?
P2860
Q26830005-C9BF02BB-5059-4581-B433-C23BCF1C0C8EQ26860830-80122208-573F-41D5-B98A-33BE672F94B2Q27677998-C14700F7-E667-4788-B65A-07F36AB59B8AQ27937092-CBBD7C79-27C5-4011-8C6D-D94725E79F11Q28540830-95503147-F107-407D-BCC4-1DD63E922AD3Q28577777-491AA8E5-FE93-4F22-A973-2B288469EA23Q33749881-B3503E58-019C-431B-9194-2615EDA5605AQ33773101-71FBF0B0-E874-46BB-B891-D5725460F96FQ34022228-2B0E9F42-A2C8-404D-B1A4-66E0DED666B1Q34100842-54E3C6CD-F286-4EB3-9FA3-507D1E7094B6Q34567805-F8473DF7-BDAD-40A4-A2D2-7BF920399D52Q34792283-50DB41BB-449D-4427-BD37-0C2D2393BEBFQ36006445-4BBB7B44-9866-48C5-BAEC-36586E82BE7CQ37136725-D195F69B-0F7A-415D-BD59-E69B95FBC654Q37424784-E6B0A208-6D83-41D8-8897-10240EB55BFBQ37861180-FE3076B8-8242-4A93-8A36-971330D1E9CCQ37963498-1F464FE1-5E7A-4147-8850-E51F347B158BQ38615375-BC531681-BE09-43D6-A9C5-36CF00D9A623Q39621896-8ADF815C-78E8-46A5-95D1-06DB01CB273CQ39900095-68A8C9C8-1565-4CA8-8636-59FA4D0919BBQ40298857-71F674B4-8EEC-43D1-9394-C4770F9FE7DFQ48261265-23b5bbf6-45c5-70c4-fc4a-182a6aa4f4b6Q50949718-46E65F5C-A278-4979-8FE4-F8379C20D465Q51134492-B78107AD-E920-4927-ACF9-350897998D21Q51283531-911765B6-5BF6-474A-90BF-AFB39714AEBEQ51715690-F15D32EF-D246-402C-8996-1A0982886B48Q52323624-7B9D7B54-BE34-4A2D-A7E4-C5F5CD6F15DF
P2860
Nucleoside transporters in chronic lymphocytic leukaemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nucleoside transporters in chronic lymphocytic leukaemia.
@ast
Nucleoside transporters in chronic lymphocytic leukaemia.
@en
type
label
Nucleoside transporters in chronic lymphocytic leukaemia.
@ast
Nucleoside transporters in chronic lymphocytic leukaemia.
@en
prefLabel
Nucleoside transporters in chronic lymphocytic leukaemia.
@ast
Nucleoside transporters in chronic lymphocytic leukaemia.
@en
P2093
P2860
P356
P1433
P1476
Nucleoside transporters in chronic lymphocytic leukaemia.
@en
P2093
Bellosillo B
Molina-Arcas M
Pastor-Anglada M
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403271
P577
2004-03-01T00:00:00Z